IP Library Granted Patent US 11,136,594
Granted Patent B2
US 11,136,594 · App. 15/063,929 · Granted Oct 5, 2021

Method for production of reprogrammed cell using chromosomally unintegrated virus vector

Inventors: Noemi Fusaki (Tsukuba, JP); Hiroshi Ban (Tsukuba, JP); Mamoru Hasegawa (Tsukuba, JP); Yoshikazu Yonemitsu (Chiba, JP)
Assignee: ID PHARMA CO., LTD.
C12N15/86C07K14/4702C12N5/0696C12N7/00C12N2501/60C12N2501/602C12N2501/603C12N2501/604C12N2501/606C12N2510/00C12N2760/18622C12N2760/18643C12N2760/18645C12N2760/18662C12N2760/18822C12N2760/18843
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,136,594
App. No.
15/063,929
Granted
Oct 5, 2021
Kind
B2
Abstract

An objective of the present invention is to provide vectors for conveniently and efficiently producing ES-like cells in which foreign genes are not integrated into the chromosome. The present inventors discovered methods for producing ES-like cells from somatic cells using chromosomally non-integrating viral vectors. Since no foreign gene is integrated into the chromosome of the produced ES-like cells, they are advantageous in tests and research, and immunological rejection and ethical problems can be avoided in disease treatments.

Claims (11)

1. A Sendai virus vector having a deletion of F gene, and encoding an M protein having mutations of G69E, T116A, and A183S, an HN protein having mutations of A262T, G264R, and K461G, a P protein having mutations of L511F, and a L protein having mutations of N1197S and K1795E, wherein viral protein(s) encoded in said Sendai virus vector further comprises mutations of any one of (i) to (iv) below:

(i) D433A, R434A and K437A in the P protein, and L1361C and L1558I in the L protein

(ii) D433A, R434A and K437A in the P protein;

(iii) Y942H, L1361C and L1558I in the L protein; and

(iv) D433A, R434A and K437A in the P protein, and L1558I in the L protein,

and wherein the Sendai virus vector can be used for expressing reprograming factor genes in a somatic cell to induce an induced pluripotent stem cell.

2. A method for introducing one or more foreign genes into a single cell comprising introducing the Sendai virus vector according to claim 1 into the cell.

3. The method according to claim 2 , further comprising the step of elevating the incubating temperature to remove said vectors.

4. The method according to claim 3 , wherein the incubating temperature is elevated to 37.5° C. to 39° C.

5. A composition for introducing one or more foreign genes into a single cell, comprising a carrier or diluent and the Sendai virus vector according to claim 1 .

6. The composition according to claim 5 , further comprising a Sendai virus vector having a deletion of F gene and encoding an M protein comprising the mutations of G69E, T116A, and A183S, an HN protein comprising the mutations of A262T, G264R, and K461G, a P protein comprising the mutation of L511F, and an L protein comprising the mutations of N1197S and K1795E.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 10, 2016
From: FUSAKI, NOEMI; BAN, HIROSHI; HASEGAWA, MAMORU; YONEMITSU, YOSHIKAZU
To: DNAVEC CORPORATION
Reel/Frame 037943/0630 →
CHANGE OF NAME Recorded Mar 10, 2016
From: DNAVEC CORPORATION
To: ID PHARMA CO., LTD.
Reel/Frame 038056/0748 →
Continuity (3)
Continuation 14812108 · Jul 29, 2015
Division 13054022
Related Publication 20160177337A1 · Jun 23, 2016